286 related articles for article (PubMed ID: 23957507)
1. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.
Minelli A; Maffioletti E; Bortolomasi M; Conca A; Zanardini R; Rillosi L; Abate M; Giacopuzzi M; Maina G; Gennarelli M; Bocchio-Chiavetto L
Acta Psychiatr Scand; 2014 Jun; 129(6):461-6. PubMed ID: 23957507
[TBL] [Abstract][Full Text] [Related]
2. Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients.
Minelli A; Zanardini R; Abate M; Bortolomasi M; Gennarelli M; Bocchio-Chiavetto L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1322-5. PubMed ID: 21570438
[TBL] [Abstract][Full Text] [Related]
3. Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression.
Bilgen AE; Bozkurt Zincir S; Zincir S; Ozdemir B; Ak M; Aydemir E; Sener I
Brain Res Bull; 2014 May; 104():82-7. PubMed ID: 24747833
[TBL] [Abstract][Full Text] [Related]
4. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
[TBL] [Abstract][Full Text] [Related]
5. Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder.
Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
Brain Behav; 2021 Aug; 11(8):e02001. PubMed ID: 34342142
[TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
[TBL] [Abstract][Full Text] [Related]
7. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
8. Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot study.
Kranaster L; Blennow K; Zetterberg H; Sartorius A
J Affect Disord; 2019 Jun; 253():449-453. PubMed ID: 31103810
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of electroconvulsive therapy and antidepressants in depression.
Avery D; Winokur G
Biol Psychiatry; 1977 Aug; 12(4):507-23. PubMed ID: 889984
[TBL] [Abstract][Full Text] [Related]
10. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
[TBL] [Abstract][Full Text] [Related]
11. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
[TBL] [Abstract][Full Text] [Related]
12. [Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder].
Ozsoy S; Eşel E; Hacimusalar Y; Candan Z; Kula M; Turan T
Turk Psikiyatri Derg; 2008; 19(4):341-8. PubMed ID: 19110975
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.
Kruse JL; Congdon E; Olmstead R; Njau S; Breen EC; Narr KL; Espinoza R; Irwin MR
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29489077
[TBL] [Abstract][Full Text] [Related]
14. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.
Stelzhammer V; Guest PC; Rothermundt M; Sondermann C; Michael N; Schwarz E; Rahmoune H; Bahn S
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1199-207. PubMed ID: 23183131
[TBL] [Abstract][Full Text] [Related]
15. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein.
Palmio J; Huuhka M; Laine S; Huhtala H; Peltola J; Leinonen E; Suhonen J; Keränen T
Psychiatry Res; 2010 May; 177(1-2):97-100. PubMed ID: 20378182
[TBL] [Abstract][Full Text] [Related]
16. Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy.
Winkler D; Pjrek E; Lanzenberger R; Baldinger P; Eitel D; Kasper S; Frey R
J Psychiatr Res; 2014 Oct; 57():96-100. PubMed ID: 24998016
[TBL] [Abstract][Full Text] [Related]
17. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
[TBL] [Abstract][Full Text] [Related]
18. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder.
Watts BV; Groft A
J ECT; 2010 Sep; 26(3):213-7. PubMed ID: 20386115
[TBL] [Abstract][Full Text] [Related]
20. VEGF serum levels in depressed patients during SSRI antidepressant treatment.
Ventriglia M; Zanardini R; Pedrini L; Placentino A; Nielsen MG; Gennarelli M; Bocchio-Chiavetto L
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):146-9. PubMed ID: 19059450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
